During the past decade, Milestone Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Milestone Research" #1 sponsor was "Pfizer" with 8 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Acasti Pharma Inc." with 1 trials sponsored and "Antibe Therapeutics Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Milestone Research" #1 collaborator was "Assurex Health Ltd." with 1 trials as a collaborator, "Centre for Addiction and Mental Health" with 1 trials as a collaborator, "Genome Canada" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "JSS Medical Research Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Milestone Research" are "Obesity" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Atopic Dermatitis" (1 trials), "Atrial Fibrillation" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "Milestone Research" in a lesser frequency.

Most popular intervention types in "Milestone Research" are "Drug" (14 trials), "Other" (6 trials), "Biological" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Tirzepatide" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials) and "ATB-346 low dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Milestone Research" are 19 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Milestone Research". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Milestone Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Milestone Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".